Nils Werner

GLP-1 Receptor Agonists in Dentistry: Promise, Pitfalls, and Evidence Gaps

GLP-1RAs (glucagon-like peptide-1 receptor agonists) have become one of the fastest-growing drug classes worldwide, with prescriptions for obesity treatment increasing by 587% from 2019 to 2024. While their metabolic and cardiovascular benefits are well established, the implicati...